Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment

PHASE3TerminatedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

October 20, 2016

Conditions
Cutaneous Hypersensitivity
Interventions
DRUG

Desloratadine + Prednisolone

Children (2 to 5 years): 2.5 ml 3 times a day Children (6 to 12 years): 5.0 ml 3 times a day

DRUG

Dexchlorpheniramine + Betamethasone

Children (2 to 5 years): 2.5 ml 3 times a day Children (6 to 12 years): 5.0 ml 3 times a day

Trial Locations (3)

Unknown

Allergisa, Campinas

Alergoalpha, São Paulo

Hospital Nipo Brasileiro, São Paulo

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EMS

INDUSTRY

NCT01529242 - Comparison of Desloratadine Associated With Prednisolone Oral Solution Versus Dexchlorpheniramine Associated With Betamethasone for Cutaneous Rash Treatment | Biotech Hunter | Biotech Hunter